E Yakoumakis
National and Kapodistrian University of Athens
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by E Yakoumakis.
Pediatric Radiology | 2003
Konstantinos A. Gogos; E Yakoumakis; Ioannis A. Tsalafoutas; Triantafillia Makri
BackgroundFor paediatric radiology, diagnostic reference levels (DRLs) have been proposed by the National Radiological Protection Board and the European Commission, representing a baseline above which re-evaluation of the equipment and the techniques used is necessary.ObjectiveTo measure the entrance surface dose (ESD) in various paediatric radiological examinations carried out at a large paediatric hospital in Greece and compare them with the existing DRLs.Materials and methodsMeasurements of ESD using thermoluminescent dosemeters were carried out in a sample of 168 paediatric patients who underwent various common radiological examinations (chest, skull, pelvis, lumbar spine, full spine). The patients were categorised according to age, and the mean ESD was calculated for each examination and age category. Additionally, the effective doses were estimated from measured ESD using appropriate conversion coefficients found in the literature.ResultsThe mean ESD values were found to be well below the proposed DRLs for all the examinations studied except for the chest, owing to the low tube potential used and tube filtration.ConclusionsEven in examinations that did not exceed the DRL, patient protection can be optimised further by appropriate collimation of field size to that necessary for diagnosis.
Oncology | 1998
N. Baziotis; E Yakoumakis; A. Zissimopoulos; X. Geronicola-Trapali; J. Malamitsi; Ch. Proukakis
Sixty-four patients with painful metastatic breast cancer in bone were treated with 2 MBq/kg of strontium-89 chloride as a single intravenous injection. Patients were followed with records of medication, hematology parameters, serial bone and Sr-89 bremsstrahlung images and with a point pain score scale (10–0). The response was assessed during a 6-month period of follow-up. Fifty-two of 64 patients (81%) showed at least a moderate improvement. Eighteen out of the 52 responders showed a dramatic decrease in bone pain (35%), 21 (40%) presented a satisfactory response and in 13 cases (25%) the response was moderate. Only 12 patients (19%) from the whole group did not feel any improvement on pain palliation. A statistically significant decrease of pretreatment levels of platelets and leukocyte counts was observed after 4–6 weeks of therapy in 50 (70%) patients. Although most patients showed no change in their bone scans after 3 months of treatment, an obvious improvement was observed in 3 of them. Furthermore no additional painful metastases on their bone scintigraphic images were observed. The selective strontium-89 local uptake in metastatic sites was also confirmed directly by bremsstrahlung scans which were absolutely comparable to the respective 99mTc bone scans. Precautions have been taken against Sr-89 contamination from the patients’ blood or excretions.
Journal of Radiological Protection | 2009
E Yakoumakis; G. Gialousis; Despina Papadopoulou; Triantafillia Makri; Zografia Pappouli; Nikolaos E. Yakoumakis; Panayotis Papagiannis; Evangelos Georgiou
Entrance surface radiation doses were measured with thermoluminescent dosimeters for 98 children who were referred to a cardiology department for the diagnosis or the treatment of a congenital heart disease. Additionally, all the radiographic parameters were recorded and Monte Carlo simulations were performed for the estimation of entrance surface dose to effective dose conversion factors, in order to further calculate the effective dose for each child. For diagnostic catheterisations the values ranged from 0.16 to 14.44 mSv, with average 3.71 mSv, and for therapeutic catheterisations the values ranged from 0.38 to 25.01 mSv, with average value 5 mSv. Effective doses were estimated for diagnostic procedures and interventional procedures performed for the treatment of five different heart diseases: (a) atrial septal defect (ASD), (b) ventricular septal defect (VSD), (c) patent ductus arteriosus (PDA), (d) aorta coarctation and (e) pulmonary stenosis. The high levels of radiation exposure are, however, balanced with the advantages of cardiac catheterisations such as the avoidance of surgical closure and the necessity of shorter or even no hospitalisation.
Physics in Medicine and Biology | 2011
A. Dimitriadis; G. Gialousis; Triantafillia Makri; M Karlatira; P. Karaiskos; E. Georgiou; S Papaodysseas; E Yakoumakis
Organ doses are important quantities in assessing the radiation risk. In the case of children, estimation of this risk is of particular concern due to their significant radiosensitivity and the greater health detriment. The purpose of this study is to estimate the organ doses to paediatric patients undergoing barium meal and micturating cystourethrography examinations by clinical measurements and Monte Carlo simulation. In clinical measurements, dose-area products (DAPs) were assessed during examination of 50 patients undergoing barium meal and 90 patients undergoing cystourethrography examinations, separated equally within three age categories: namely newborn, 1 year and 5 years old. Monte Carlo simulation of photon transport in male and female mathematical phantoms was applied using the MCNP5 code in order to estimate the equivalent organ doses. Regarding the micturating cystourethrography examinations, the organs receiving considerable amounts of radiation doses were the urinary bladder (1.87, 2.43 and 4.7 mSv, the first, second and third value in the parentheses corresponds to neonatal, 1 year old and 5 year old patients, respectively), the large intestines (1.54, 1.8, 3.1 mSv), the small intestines (1.34, 1.56, 2.78 mSv), the stomach (1.46, 1.02, 2.01 mSv) and the gall bladder (1.46, 1.66, 2.18 mSv), depending upon the age of the child. Organs receiving considerable amounts of radiation during barium meal examinations were the stomach (9.81, 9.92, 11.5 mSv), the gall bladder (3.05, 5.74, 7.15 mSv), the rib bones (9.82, 10.1, 11.1 mSv) and the pancreas (5.8, 5.93, 6.65 mSv), depending upon the age of the child. DAPs to organ/effective doses conversion factors were derived for each age and examination in order to be compared with other studies.
Radiation Protection Dosimetry | 2011
G. Gialousis; A. Dimitriadis; E Yakoumakis
Lung brachytherapy using high-dose rate (192)Ir technique is a well-established technique of radiation therapy. However, many commercial treatment planning systems do not have the ability to consider the inhomogeneity of lung in relation to normal tissue. Under such circumstances dose calculations for tissues and organs at risk close to the target are inaccurate. The purpose of the current study was to estimate the dose difference due to tissue inhomogeneity using the Monte Carlo simulation code MCNP-5. Results showed that there was a relative sub dosage by treatment planning systems calculations in neighbouring tissues around the radioactive source due to inhomogeneity ignorance. The presence of lung instead of normal tissue resulted in an increase in relative dose, which approached 8 % at 4-cm distance from the source. Additionally, the relative increase was small for the lung (2.1 %) and larger for organs at risk such as the heart (6.8 %) and bone marrow (7.6 %).
Health Physics | 2008
G. Gialousis; E Yakoumakis; Anastasios I. Dimitriadis; Zografia K. Papouli; Nikolaos E. Yakoumakis; Ioannis A. Tsalafoutas; Despoina I. Papadopoulou; Evangelos Georgiou
Radiation exposure was investigated for children undergoing various common radiographies in three dedicated pediatric hospitals in Greece. Kerma in air at the entrance of the beam (Ka,e) was measured with thermoluminescent dosimeters. Ka,e values ranged from 0.09 mGy to 5.52 mGy and were found to be greater in Hospital C, because of the increased high voltage and time-current product used by the radiation technologists. Equivalent doses in red bone marrow and breast were estimated with Monte Carlo simulation by PCXMC code. Values ranged from 2 &mgr;Sv to 204 &mgr;Sv for red bone marrow and from 0 to 817 &mgr;Sv for breast. Variation in doses occurred due to field size, high voltage setting, and Ka,e.
British Journal of Radiology | 2001
E Yakoumakis; Ioannis A. Tsalafoutas; D Nikolaou; I Nazos; E D Koulentianos; Ch. Proukakis
British Journal of Radiology | 2007
V Tsapaki; Ioannis A. Tsalafoutas; I Chinofoti; A Karageorgi; E Carinou; V Kamenopoulou; E Yakoumakis; E D Koulentianos
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology | 2001
E Yakoumakis; Christine E. Tierris; Ioannis G. Phanourakis; Charalambos Proukakis
Radiation Protection Dosimetry | 2004
Christine E. Tierris; E Yakoumakis; George N. Bramis; Evangelos Georgiou